Sharon H. Giordano, MD, MPH, FASCO
Department of Breast Medical Oncology, Division of Cancer Medicine
Experience & Service
Intramural Institutional Committee Activities
Member, Faculty Awards Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Extramural Institutional Committee Activities
Member, Diagnostic Imaging Division Head Search Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Member, New Department Creation Committee, The University of Texas MD Anderson Cancer Center, 2026 - Present
Member, Clinical Term-Tenure/Term-Tenure Track Hiring Panel, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Institutional Capital Management Committee (ICMC), The University of Texas MD Anderson Cancer Center, 2025 - Present
Chair, Committee of Chairs, The University of Texas MD Anderson Cancer Center, 2025 - Present
Reviewer, Margaret L. Kripke Legend Award, The University of Texas MD Anderson Cancer Center, 2025 - Present
Reviewer, Data Science Faculty Recruitment Committee, The University of Texas MD Anderson Cancer Center, 2025 - 2025
Member, Research Enterprise Evolution Initiative - Clinical Research Optimization, The University of Texas MD Anderson Cancer Center, 2025 - 2025
Member, Advisory Committee, Prostate Center Demonstration Project, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, John Mendelsohn Award for Faculty Leadership, The University of Texas MD Anderson Cancer Center, 2025 - 2025
Member, Mendelsohn Award Review Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, President’s Advisory Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Institutional Capital Management Committee (ICMC), The University of Texas MD Anderson Cancer Center, 2025 - Present
Member, Charles A. LeMaistre Outstanding Achievement Award in Cancer Selection Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Academic Policy Council, The University of Texas MD Anderson Cancer Center, 2024 - Present
Chair Elect, Committee of Chairs, The University of Texas MD Anderson Cancer Center, 2024 - 2025
Member, Priority Review Committee for Institutional Philanthropy (PRC), The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Academic Mentoring Council (AMC), The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Standing Committee on Faculty Awards, The University of Texas MD Anderson Cancer Center, 2023 - Present
Internal Advisory Committee Member, Texas Health Equity Alliance for Breast Cancer (THEAL), The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Academic Leadership Team Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Internal Advisory Board Member, Prostate Cancer SPORE, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Value Task Force, The University of Texas MD Anderson Cancer Center, 2022 - 2022
Internal Advisory Board Member, Morgan Welch Inflammatory Breast Cancer Program, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Faculty Vitality Taskforce, The University of Texas MD Anderson Cancer Center, 2019 - 2023
Member, Endowed Positions & Award Committee (EPAC), The University of Texas MD Anderson Cancer Center, 2019 - 2022
Voting Rotating Member, Epidemiology Database Access Committee, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, Radiation Oncology Division Head Search Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019
Member, Department of Breast Medical Oncology Assistant Professor (Tenure Track) Search Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2022
Chair, Internal Advisory Board, U-HAND (University of Houston/MD Anderson Program to Reduce Cancer Disparities), The University of Texas MD Anderson Cancer Center, 2017 - 2022
Advisory Committee Member, Susan G. Komen Training Program to Reduce Breast Cancer Disparities in Black and Hispanic Women, The University of Texas MD Anderson Cancer Center, 2017 - 2020
Member, Vice Provost Population Science Advisory Council (VP-PSAC), The University of Texas MD Anderson Cancer Center, 2017 - 2018
Member, Community of Chairs, The University of Texas MD Anderson Cancer Center, 2017 - Present
Member, Community of Science Chairs, The University of Texas MD Anderson Cancer Center, 2017 - Present
Co-Chair, Epidemiology Department Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2018
Member, Breast Cancer Moonshot Scientific Advisory Board, The University of Texas MD Anderson Cancer Center, 2016 - 2017
Co-Chair, Gastroenterology, Hepatology & Nutrition Department Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2017
Member, UT Population Health Strategic Plan Steering Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2016
Member, Department of Health Disparities Research Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2017
Distinguished Judge, Cyrus Scholar Awards, The University of Texas MD Anderson Internal Medicine Research Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2016
Member, Breast Surgical Oncology Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2016
Member, Executives and Non-faculty Leaders Team, The University of Texas MD Anderson Cancer Center, 2014 - 2015
Member, Clinical Effectiveness Subcommittee, The University of Texas MD Anderson Cancer Center, 2014 - 2015
Member, Faculty Diversity, Equity, and Inclusion Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2023
Member, Department of Pathology Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2015
Reviewer, Population Science Abstracts, Trainee Research Day, The University of Texas MD Anderson Cancer Center, 2014
Member, Department of Breast Medical Oncology Assistant Professor (Tenure Track) Search Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2015
Member, MINTOS Grant Review Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2013
Executive Advisory Board, Cancer Prevention Research Training Program (CPRTP) Advisory Committee, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, Institutional Research Executive Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2016
Member, Center for Radiation Oncology Internal Advisory Board, The University of Texas MD Anderson Cancer Center, 2013 - 2016
Member, Gynecologic Oncology and Reproductive Medicine Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2013
Executive Committee Member, Duncan Family Institute for Cancer Prevention and Risk Assessment, The University of Texas MD Anderson Cancer Center, 2013 - Present
Member, Institute for Cancer Care Innovation Leadership Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2017
Member, Institute for Cancer Care Executive Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2017
Member, Institutional Review Board IV, The University of Texas MD Anderson Cancer Center, 2012 - 2013
Chair, Department of Breast Medical Oncology Assistant Professor (Tenure Track) Search Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2012
Member, Division of Cancer Medicine Sixth Annual Faculty Recognition and Awards Program Review Board, The University of Texas MD Anderson Cancer Center, 2011 - 2011
Chair, Department of Health Services Research Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2011
Member, Department of Breast Medical Oncology Strategic Planning Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2012
Member, Health Services Research Chair Search Committee, The University of Texas MD Anderson Cancer Center, 2010
Chair, Clinical Effectiveness Subcommittee-Breast Cancer, The University of Texas MD Anderson Cancer Center, 2008
Member, Breast Cancer Guideline Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2014
Director, Educational & Training Program, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 2007 - 2012
Faculty Member, Hematology/Oncology Fellowship Steering Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2012
Chair, Department of Breast Medical Oncology Concept and Protocol Review Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2008
Member, Clinical Safety and Effectiveness Committee, The University of Texas MD Anderson Cancer Center, 2007
Member, Survivorship Clinical Research Work Group, The University of Texas MD Anderson Cancer Center, 2007
Member, Department of General Internal Medicine Search Committee, The University of Texas MD Anderson Cancer Center, 2007
Vice-Chair, Department of Breast Medical Oncology Concept and Protocol Review Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2007
Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2007
Member, Women Faculty Salary Equity Study Group, The University of Texas MD Anderson Cancer Center, 2006 - 2007
Committee Vice Chair, Institutional Review Board IV, The University of Texas MD Anderson Cancer Center, 2005 - 2012
Member, Institutional Review Board III, The University of Texas MD Anderson Cancer Center, 2005 - 2012
Associate Member, Institutional Review Board I, The University of Texas MD Anderson Cancer Center, 2005 - 2012
Associate Member, Institutional Review Board II, The University of Texas MD Anderson Cancer Center, 2005 - 2012
Member, Psychosocial, Behavioral, and Health Services Research Committee (PBHSRC), The University of Texas MD Anderson Cancer Center, 2005 - 2007
Member, Breast Center FMEA Committee, The University of Texas MD Anderson Cancer Center, 2005 - 2006
Alternate Member, Pharmacy and Therapeutics Committee, The University of Texas MD Anderson Cancer Center, 2004 - 2006
Editorial Activities
Editorial Board Member, Journal of Clinical Oncology, 2018 - 2023
Editorial Board Member, Journal of the National Cancer Institute, 2017 - 2022
Editorial Board Member, Journal of Clinical Oncology, 2007 - 2013
Editorial Advisory Board Member, CANCER, 2006 - 2021
Honors & Awards
| 2026 - Present | Perfect Score Provider, The University of Texas MD Anderson Cancer Center |
| 2026 | Gianni Bonadonna Breast Cancer Award, American Society of Clinical Oncology |
| 2025 - Present | Top 1% in the nation, Physicians Referral Service and Patient Experience |
| 2025 | MD Anderson’s Celebration of Faculty Excellence, The University of Texas MD Anderson Cancer Center |
| 2024 | Hologic, Inc Endowed Women Who Conquer Cancer Mentorship Award, Conquer Cancer Foundation, American Society of Clinical Oncology |
| 2022 | President's Recognition of Faculty Excellence Award, Clinical Quality Improvement, The University of Texas MD Anderson Cancer Center |
| 2020 | Jack and Beverly Randall Excellence in Cancer Care Award, MD Anderson Cancer Center Jack and Beverly Randall Endowment |
| 2019 | Excellence in LEADership Award, The University of Texas MD Anderson Cancer Center |
| 2019 | President's Recognition of Faculty Excellence Award in Education & Mentorship Advancement, The University of Texas MD Anderson Cancer Center |
| 2017 | Fellow of the American Society of Clinical Oncology, American Society of Clinical Oncology |
| 2015 - 2025 | Komen Scholar |
| 2013 | UT Regents' Outstanding Teaching Award Nominee, MD Anderson Cancer Center |
| 2013 | The Teaching Department of the Year - Breast Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center |
| 2012 - 2015 | Faculty Scholar Award, The University of Texas MD Anderson Cancer Center |
| 2011 | Division of Cancer Medicine Mentor of the Year, The University of Texas MD Anderson Cancer Center |
| 2010 | Division of Cancer Medicine Distinguished Alumnus Award, The University of Texas MD Anderson Cancer Center |
| 2009 - 2014 | American Cancer Society Research Scholar, American Cancer Society |
| 2009 | Tracy Starr Breast Cancer Research Fund Award, Cleveland Foundation |
| 2009 | Faculty Educator of the Month - July, The University of Texas MD Anderson Cancer Center |
| 2009 | Gerald P. Bodey Award for Excellence in Education Nominee, The University of Texas MD Anderson Cancer Center |
| 2007 | Fellow, Sealy Center on Aging, The University of Texas Medical Branch at Galveston |
| 2004 - 2009 | Recipient, NIH Loan Repayment Program, National Institutes of Health |
| 2002 - 2004 | Breast Medical Oncology Certificates of Appreciation: Highest Revenue per % Effort and Highest Number of RVUs per % Effort, The University of Texas MD Anderson Cancer Center |
| 2002 | M. D. Anderson Trainee Recognition Day Honorable Mention, The University of Texas MD Anderson Cancer Center |
| 2001 - 2002 | ASCO Merit Award Recipient, American Society of Clinical Oncology |
| 2001 | Outstanding New Student Award, UT School of Public Health |
| 1996 | Alpha Omega Alpha, Johns Hopkins University School of Medicine |
| 1991 | Graduated With Distinction in Biology and Summa Cum Laude, Yale University |
| 1990 | Outstanding Student in Organic Chemistry Laboratory, Yale University |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. QOL Through Treatment- Coping with Fatigue and Nausea. Invited. MBC Impact Series webinar. Houston, Texas, US.
- 2022. Systemic Therapy for Early Breast Cancer. Invited. 2022 Comprehensive Board Review in Hematology and Medical Oncology. Houston, Texas, US.
- 2022. Introduction to Health Services Research. Invited. Monthly Abdominal Imaging Research Lecture Series (MARS). Houston, Texas, US.
- 2014. Breakthrough Houston College Prep Enrichment Program. Invited. MD Anderson Women Faculty Programs. Houston, Texas, US.
- 2014. Opportunities in Health Services Research. Invited. Clinical Research and Education Unit (CREU). Houston, Texas, US.
- 2014. Work Life Integration Seminar. Invited. Hematology and Medical Oncology Fellowship Program. Houston, Texas, US.
- 2014. Opportunities in Health Services Research. Invited. Cancer Prevention and Control Grand Rounds. Houston, Texas, US.
- 2013. Male Breast Cancer. Invited. The SCAR Project. Houston, Texas, US.
- 2013. Panel Discussion: Health Services Research: A New Horizon. Invited. Women Executives in Science & Healthcare. Houston, Texas, US.
- 2012. Breast Cancer: Progress Through Understanding. Invited. Inaugural Hope in Houston: Hot Pink Luncheon. Houston, Texas, US.
- 2012. Outcomes and Quality of Cancer Treatment in Cancer Survivors. Invited. Advances in Oncology Institutional Grand Rounds. Houston, Texas, US.
- 2011. Metastatic Breast Cancer. Invited. Hematology and Medical Oncology Fellowship Program. Houston, Texas, US.
- 2011. Metastatic Breast Cancer: HER2 Negative. Invited. Hematology and Medical Oncology Fellowship Program. Houston, Texas, US.
- 2011. Cardiac Toxicity in Breast Cancer Survivors. Invited. Grands Rounds. Houston, Texas, US.
- 2010. Potential Research Applications of Cancer Registry and Administrative Datasets. Invited. Health Services Research Journal Club. Houston, Texas, US.
- 2010. HSR Today at MD Anderson Cancer Center. Invited. Health Services Research Retreat. Houston, Texas, US.
- 2010. Potential Research Applications of Cancer Registry and Administrative Datasets. Invited. Division of Cancer Medicine Grand Rounds. Houston, Texas, US.
- 2009. Male Breast Cancer. Invited. Core Curriculum Lecture. Houston, Texas, US.
- 2009. Male Breast Cancer. Invited. Breast Cancer Nurses Lecture Series. Houston, Texas, US.
- 2009. Male Breast Cancer. Invited. Core Curriculum Lecture. Houston, Texas, US.
- 2009. Treatment Paradigm for Breast Cancer. Invited. The Gynecology Oncology Fellowship Program Education Conference. Houston, Texas, US.
- 2007. Breast Cancer in Men, The Surgical Breast Education Conference. Invited. The Surgical Oncology Fellowship and Breast Surgical Oncology Fellowship Program. Houston, Texas, US.
- 2007. Principles of Male Breast Cancer. Invited. Core Curriculum Lecture. Houston, Texas, US.
- 2006. Uses of SEER and SEER-Medicare Data in Cancer Research. Invited. Cancer Medicine Grand Rounds. Houston, Texas, US.
- 2006. Uses of SEER and SEER-Medicare Data in Cancer Research. Invited. Department of Internal Medicine Research Conference. Houston, Texas, US.
- 2005. Cardiac Morbidity of Adjuvant Radiotherapy (ART) in Patients with Early Stage Breast Cancer Poster Presentation. Invited. Houston, Texas, US.
- 2005. Diagnosis and Treatment of Primary Breast Cancer. Invited. 27th annual Pharmacy Symposium on Cancer Chemotherapy. Houston, Texas, US.
- 2004. Male Breast Cancer. Invited. Houston, Texas, US.
- 2004. Effects of Treatment and Survivorship of Advanced Breast Cancer. Invited. Grand Rounds and Alice Judkins Lectureship. Houston, Texas, US.
- 2003. Breast Cancer in Men. Invited. Grand Rounds. Houston, Texas, US.
Regional Presentations
- 2018. Toxicities of Breast Cancer Treatments. Invited. 2018 Scholar Breakfast. Plano, TX, US.
- 2015. Panel Discussion: Cancer Survivorship: Improving Care and Quality of Life. Invited. Fort Worth, TX, US.
- 2015. Toxicities of Breast Cancer Treatment. Invited. Fort Worth, TX, US.
- 2010. Use of SEER-Medicare Data in Cancer Treatment and Outcomes Research. Invited. Cancer Center Grand Rounds. Galveston, TX, US.
National Presentations
- 2026. Her-2 and Hormone Receptor Positive Breast Cancer. Invited. 22nd Oncology Update: Advances and Controversies.
- 2024. Systemic Therapy for Breast Cancer. Invited. 2024 Comprehensive Board Review in Hematology and Medical Oncology, US.
- 2024. Assessing early and late toxicities of cancer treatment with registry-based data. Invited. Cancer Outcomes Research, NC, US.
- 2024. Assessing early and late toxicities of cancer treatment with registry-based data. Invited. UNC, NC, US.
- 2023. Male Breast Cancer. Invited, US.
- 2023. Male Patients With Breast Cancer: Special Considerations and Gender-Specific Concerns. Invited, US.
- 2023. Determinants of Health in the Marginalized: Mechanisms and Mediators. Conference. Chicago, IL, US.
- 2022. Systemic Therapy for Early Breast Cancer. Invited. 2022 Comprehensive Board Review in Hematology and Medical Oncology, US.
- 2021. Special Issues in Breast Cancer. Invited. 2021 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2019. The Toll on Health Care Providers. Conference. San Antonio, TX, US.
- 2019. Male Breast Cancer. Invited. Current Controversies Meeting. Boston, MA, US.
- 2018. Session Chair. Conference. Spotlight Session: Quality of Life, Survivorship and Cost of Care. San Antonio, TX, US.
- 2018. Special Issues in Breast Cancer. Invited. 2018 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2018. Highlights in Male Breast Cancer. Invited. 2018 Best of ASCO Puerto Rico. Puerto Rico, PR, US.
- 2018. Updates on HER2-Positive Breast Cancer Treatment. Invited. Orlando, FL, US.
- 2018. Toxicities of Breast Cancer Treatments. Invited. Susan G. Komen North Texas Breast Health Lecture Series. Plano, TX, US.
- 2017. Poster Discussant. Conference. Spotlight Session - Cost/Fertility Preservation/Male Breast Cancer. San Antonio, TX, US.
- 2016. Special Issues in Breast Cancer. Invited. 2016 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2016. Discussant. Conference. Oral Abstract Session B Breakout 2: Science of Quality. Chicago, IL, US.
- 2015. Special Issues in Breast Cancer. Invited. 2015 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2015. Overview of Comparative Effectiveness Research and Observational Study Design. Conference. Chicago, IL, US.
- 2015. Use of Registry and Administrative Data in Cancer Outcomes Research. Invited. University of Puerto Rico Medical Sciences Grand Rounds. San Juan, PR, US.
- 2015. Use of Registry and Administrative Data in Cancer Outcomes Research. Invited. San Juan, PR, US.
- 2015. Assessing Toxicity of Therapy with Administrative Data. Invited. Dana-Farber Cancer Institute Breast Oncology Seminar. Boston, MA, US.
- 2015. Assessing Toxicity of Therapy with Administrative Data. Invited. Boston, MA, US.
- 2014. Special Issues in Breast Cancer. Invited. 2014 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2014. Long-Term Health Outcomes. Conference. 2014 Breast Cancer Symposium. San Francisco, CA, US.
- 2014. Scientific Discussant. Conference. Breast Cancer - HER2/ER Oral Abstract Session. Chicago, IL, US.
- 2013. Special Issues in Breast Cancer. Invited. 2013 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2012. Special Issues in Breast Cancer. Invited. 2012 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2012. Scientific Discussant. Conference. Health Services Research Poster Session. Chicago, IL, US.
- 2011. Special Issues in Breast Cancer. Invited. 2011 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2010. Special Issues in Breast Cancer. Invited. 2010 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2010. Impact of Comorbid Conditions on Breast Cancer Survivorship. Conference. Chicago, IL, US.
- 2010. Use of SEER-Medicare Data in Cancer Treatment and Outcomes Research. Invited. The University of Texas Medical Branch Cancer Center. Galveston, TX, US.
- 2009. Special Issues in Breast Cancer. Invited. 2009 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2009. Current Update on Medical Oncology Approach to Common Malignancies: Breast Cancer - What the Surgeon Needs to Know. Invited. AO North America and AO Spine North America. Houston, TX, US.
- 2008. New Options for Metastatic Breast Cancer. Invited. Amarillo, TX, US.
- 2008. Expert Discussion of Breast Cancer Nursing Practice Patterns: Adjuvant Therapies. Invited. Seattle, WA, US.
- 2008. Risk and Prognostic Factors. Invited. Male Breast Cancer Meeting: A Multidisciplinary Scientific Update Meeting. Rockville, MD, US.
- 2008. Anthracyclines and HER2 Inhibitors: Benefits vs. Risks. Invited. Philadelphia, PA, US.
- 2008. Advanced Disease Therapy. Invited. Breast Cancer Highlights Meeting. Santa Monica, CA, US.
- 2008. Sequence of Treatment in Stage 4 Disease. Invited. 8th Annual Oncology Update: Advances and Controversies. Park City, UT, US.
- 2007. Update on the Treatment of Metastatic Breast Cancer. Invited. Santa Barbara, CA, US.
- 2007. Update on the Treatment of Early Stage Breast Cancer. Invited. Santa Barbara, CA, US.
- 2007. Treatment Patterns for Breast Cancer. Invited. CISNET Breast Mid-Year Meeting. Houston, TX, US.
- 2007. Treatment Options for Anthracycline and Taxane Refractory Metastatic Breast Cancer. Invited. Reality Hematology/Oncology Meeting. St. Louis, MO, US.
- 2007. Management of HER-2 Positive Metastatic Breast Cancer. Invited. Reality Hematology/Oncology Meeting. St. Louis, MO, US.
- 2007. Update from San Antonio Breast Cancer Symposium. Invited. Chicago, IL, US.
- 2007. Update from San Antonio Breast Cancer Symposium. Invited. San Francisco, CA, US.
- 2006. Inflammatory Breast Cancer. Invited. Boston, MA, US.
- 2006. Update on the Treatment of Early Stage Breast Cancer. Invited. Baton Rouge, LA, US.
- 2006. Role of Molecular Prognostic and Predictive Factors in Clinical Practice. Invited. M. D. Anderson Physicians Network Second Annual Symposium. Kauai, HI, US.
- 2006. Advances in the Management of HER-2 Overexpressing Breast Cancer. Invited. M. D. Anderson Physicians Network Second Annual Symposium. Kauai, HI, US.
- 2006. Update on the Management of Early Stage Breast Cancer. Invited. M. D. Anderson Physicians Network Second Annual Symposium. Kauai, HI, US.
- 2006. Update from San Antonio Breast Cancer Symposium. Invited. San Francisco, CA, US.
- 2005. Cardiac Toxicity. Invited. Boston, MA, US.
- 2005. Update from ASCO Annual Meeting. Invited. Rochester, NY, US.
- 2004. Breast Cancer in 2004: An Overview. Invited. Grand Rounds. Racine, WI, US.
- 2004. Special Issues in Breast Cancer. Invited. 2004 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
- 2004. Breast Cancer in 2004: An Overview. Invited. St. Mary's Medical Center. Racine, WI, US.
- 2004. Breast Cancer in Men. Invited. 9th Annual Oncology Conference. Lake Ozark, MO, US.
- 2003. Special Issues in Breast Cancer. Invited. 2003 Comprehensive Board Review in Hematology and Medical Oncology. Houston, TX, US.
International Presentations
- 2026. Male breast cancer: Biology and management. Invited. ESMO Breast 2026 - Educational session. Berlin, DE.
- 2025. How to treat metastatic breast cancer in men?. Invited. MULTIDISCIPLINAR DE CÂNCER DE MAMA 2025, BR.
- 2025. When to use anthracycline-taxane-based (neo)adjuvant chemotherapy in early luminal breast cancer?. Invited. MULTIDISCIPLINAR DE CÂNCER DE MAMA 2025, BR.
- 2025. Obesity, diet, physical activity, and GLP1 - GIP1 RA: What do we know today?. Invited. MULTIDISCIPLINAR DE CÂNCER DE MAMA 2025, BR.
- 2023. Systemic Therapy for Male Breast Cancer. Invited. Brussels.
- 2021. Panel Discussant. Invited. Optimal Locoregional Therapy: Treating the Axilla In Women with Breast Cancer. Virtual Worldwide.
- 2021. Adjuvant Decision Making In the Era of Limited Nodal Information. Conference. Virtual Worldwide.
- 2019. Extrapolating Data From Clinical Trials As We Are Treating Patients in Real Life. Conference. Vienna.
- 2018. Update on the Use of Potentially Cardiotoxic Therapy for the Treatment of Breast Cancer. Invited. Naples.
- 2018. Using Cancer Registry and Administrative Data to Assess Risk of Cardiotoxicity in Patients with Breast Cancer. Invited. Naples.
- 2015. Toxicities of Breast Cancer Therapies. Invited. Breast Cancer Symposium. Paris.
- 2010. Male Breast Cancer. Invited. e-grandrounds. Houston, US.
- 2009. Update on National Comprehensive Cancer Network: Breast Cancer Registry and Guidelines. Invited. Osaka.
- 2008. Cardiac Toxicity of Anthracyclines. Invited. Paris.
- 2007. Adjuvant Therapy for Post-Menopausal Women with Breast Cancer. Invited. Second National Congress of Mastology. Cartagena.
- 2007. Long Term Toxicities of Breast Cancer Therapy. Invited. Second National Congress of Mastology. Cartagena.
- 2007. Survival Benefit of Screening Mammography. Invited. Second National Congress of Mastology. Cartagena.
- 2007. Update on Trastuzumab in the Treatment of Breast Cancer. Invited. Veracruz.
- 2007. Update on Trastuzumab in the Treatment of Breast Cancer. Invited. Tijuana.
- 2006. Cardiac Toxicity of Adjuvant Anthracyclines Among Older Women with Breast Cancer. Invited. London, GB.
Grant & Contract Support
| Date: | 2027 - 2031 |
| Title: | Precision breast cancer prognosis and treatment prediction models via gene isoform-level profiles from long-read RNA-seq with multi-cohort validation |
| Funding Source: | Department of War |
| Role: | Co-I |
| ID: | BC260441 |
| Date: | 2027 - 2032 |
| Title: | Long-term consequences of exposure to immune checkpoint inhibitors in cancer patients - a population-based approach |
| Funding Source: | National Institutes of Health |
| Role: | Co-I |
| ID: | 1R01CA312052-01 |
| Date: | 2027 - 2031 |
| Title: | A gene isoform-based prediction tool for breast cancer survival and recurrence across molecular subtype |
| Funding Source: | American Cancer Society |
| Role: | Co-I |
| Date: | 2026 - 2031 |
| Title: | Effects of Centralized Cancer Care, Rural Hospital Closures, and Bypass Behavior on Outcomes Among Medicare Enrollees with Cancer |
| Funding Source: | National Institutes of Health thru University of Texas at Arlington |
| Role: | PI |
| Date: | 2026 - 2027 |
| Title: | Dual GLP-1/GIP Receptor Agonism for Mitigation of Aromatase Inhibitor-Induced Toxicities: A Pilot Biomarker Study |
| Funding Source: | The Breast Cancer Research Foundation |
| Role: | PI |
| ID: | BCRF-26-231 |
| Date: | 2026 - 2031 |
| Title: | UPR/MDACC Partnership for Excellence in Cancer Research |
| Funding Source: | National Institutes of Health |
| Role: | PI |
| ID: | 2U54CA096300-21A1 |
| Date: | 2026 - 2029 |
| Title: | Beyond per-protocol effects: improving study designs to maximize patient-choice |
| Funding Source: | Patient-Centered Outcomes Res Inst PCORI |
| Role: | Co-I |
| Date: | 2026 - 2031 |
| Title: | Gene isoform models to predict breast cancer prognosis and treatment response across molecular subtypes using long-read RNA-sequencing and deep learning |
| Funding Source: | NIH |
| Role: | Co-I |
| ID: | FP00028046 |
| Date: | 2025 - 2030 |
| Title: | Intersecting Impacts of Social Vulnerability and Structural Healthcare Inequities on Rural Cancer Disparities |
| Funding Source: | CPRIT |
| Role: | Co-I |
| ID: | PAR-22-230/ R01 |
| Date: | 2025 - 2026 |
| Title: | Efforts to Increase Representation on Prostate Cancer Clinical Trials at LBJ Hospital |
| Funding Source: | VCU Massey Cancer Center |
| Role: | Mentor |
| ID: | FP00025784 |
| Date: | 2025 - Present |
| Title: | An Engineered HER2-Directed Immunotherapy Against Metastatic Breast Cancer |
| Funding Source: | Susan G. Komen Career Catalyst Research program |
| Role: | Mentor |
| ID: | 1550869 |
| Date: | 2025 - 2029 |
| Title: | Targeting ganglioside GD2 to overcome chemotherapy-resistance in triple-negative breast cancer |
| Funding Source: | Department of Defense |
| Role: | Co-I |
| ID: | BC240226 |
| Date: | 2025 - Present |
| Title: | UTMB Women's Health Research Scholars Program |
| Funding Source: | UTMB |
| Role: | Mentor |
| ID: | 26624 |
| Date: | 2025 - 2030 |
| Title: | Increasing Uptake of Germline Genetic Testing among Prostate Cancer Patients in a Diverse Safety Net Hospital |
| Funding Source: | CPRIT |
| Role: | Mentor |
| ID: | RP250475 |
| Date: | 2025 - Present |
| Title: | UTMB Women's health research scholars program |
| Funding Source: | Institutional Research Career Development Award (BIRCWH) |
| Role: | Mentor |
| Date: | 2025 - Present |
| Title: | Development of a Brief Positive Affect Treatment (PAT) for Caregivers of Patients with Advanced Cancer |
| Funding Source: | American Cancer Society |
| Role: | Mentor |
| ID: | FP00026762 |
| Date: | 2025 - Present |
| Title: | Impact of Private Equity on Cancer care quality and equity in Medicare |
| Funding Source: | YIA |
| Role: | Mentor |
| Date: | 2024 - 2026 |
| Title: | Cancer Care Delivery and Breast Cancer: Impact and Associated Factors |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-I |
| ID: | BCRF-24-190 |
| Date: | 2024 - 2025 |
| Title: | Cancer Care Delivery and Breast Cancer: Impact and Associated Factors |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-I |
| ID: | FP00022690 |
| Date: | 2024 - 2025 |
| Title: | Delays in Timely Initiation of Treatment for Men with Prostate Cancer In Botswana |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2024 - 2026 |
| Title: | Robert A. Winn Diversity In Clinical Trials: Career Development Award |
| Funding Source: | Robert Winn Diversity in Clinical Trials Program |
| Role: | Mentor |
| Date: | 2024 - 2025 |
| Title: | Disparities in Guideline Concordant BRCA Testing for Medicare Advantage versus Traditional Medicare Beneficiaries with Breast, Ovarian, Pancreatic, and Prostate Cancers |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2023 - 2028 |
| Title: | Methods Training for Comparative Effectiveness Research in Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R25CA257883 |
| Date: | 2022 - 2026 |
| Title: | Komen Scholars |
| Funding Source: | Susan G. Komen for the Cure |
| Role: | PI |
| ID: | SAC220221 |
| Date: | 2022 - 2023 |
| Title: | Treatment Non-Completion Among Patients with Breast Cancer: Impact and Associated Factors |
| Funding Source: | Breast Cancer Research Foundation (BCRF) |
| Role: | Collaborator |
| ID: | BCRF-22-190 |
| Date: | 2022 - 2023 |
| Title: | Disparities in Adherence to Oral Anticancer Medications and Specialty Pharmacy Use |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2022 - 2027 |
| Title: | Skin Cancer Risks and Risk Prediction in Patients with Actinic Keratosis |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | 1K08CA263298-01A1 |
| Date: | 2022 - 2026 |
| Title: | Breast Cancer Treatment Initiation and Completion |
| Funding Source: | Komen Scholars |
| Role: | Collaborator |
| ID: | SAC220221 |
| Date: | 2021 - 2026 |
| Title: | Training Academic Gynecologic Oncologists |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| Date: | 2021 - 2026 |
| Title: | Data Management and Analysis Core for Comparative Effectiveness Research on Cancer in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP210130 |
| Date: | 2021 - 2026 |
| Title: | Health Benefits of Writing Therapy Among Chinese Breast Cancer Survivors |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-I |
| ID: | RSG-21-040-01-CPPB |
| Date: | 2021 - 2026 |
| Title: | Writing to Heal: A Culturally Based Brief Expressive Intervention for Chinese Immigrant Breast Cancer Survivors |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01CA248213 |
| Date: | 2021 - 2026 |
| Title: | Impact of Clonal Hematopoiesis Mutations on Toxicity and Outcomes Following Oncologic Therapy |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K08CA263313 |
| Date: | 2021 - 2025 |
| Title: | Effects of Biologic and Targeted Therapies for Rheumatoid Arthritis on Cancer Outcomes |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | R01AR078484 |
| Date: | 2019 - 2026 |
| Title: | UPR/MDACC: Partnership for Excellence in Cancer Research |
| Funding Source: | NIH/NCI |
| Role: | Contact-Principal Investigator |
| ID: | U54CA096300 |
| Date: | 2019 - 2024 |
| Title: | Developing a Decision Aid for Chemotherapy in Older Women with Early Stage Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K08CA241087 |
| Date: | 2018 - 2023 |
| Title: | Obstetrical and Oncological Outcomes Among Reproductive Age Women with Gynecological and Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K08 CA2334333 |
| Date: | 2018 - 2026 |
| Title: | Assess: A Novel Breast Cancer Decision Support Tool |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | PI |
| ID: | OG180002 |
| Date: | 2018 - 2023 |
| Title: | Genetic Testing in Young Women for Cancer Prevention |
| Funding Source: | NIH/NCI |
| Role: | Mentoring advisory committee |
| ID: | K07 CA222343 |
| Date: | 2016 - 2017 |
| Title: | International Male Breast Cancer Program of EORTC/TBCRC/BIG/NABCG: Understanding the Biology for Improved Patient Care. In Search of Valuable Biomarkers |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-PI |
| Date: | 2016 - 2023 |
| Title: | Technology Diffusion in Cancer: Geographic Variations, Facilitators, Outcomes, and Costs |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01 CA207216-01 |
| Date: | 2016 - 2021 |
| Title: | Economic Strain and Resilience in Cancer Patients: Assessing Patient-Reported Measures of the Burdens of Treatment |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | 5 K07 CA211804 |
| Date: | 2016 - 2017 |
| Title: | CCSG Supplement: Health Assessment to Advance Cancer Prevention, Screening, and Control in the MD Anderson Catchment Area: The State of Texas |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 3 P30 CA016672-41S6 |
| Date: | 2016 - 2022 |
| Title: | Comparative Effectiveness Research on Cancer in Texas (CERCIT) 2.0: Admin Core |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-PI |
| ID: | RP160674-Admin Core |
| Date: | 2016 - 2022 |
| Title: | Chemotherapy Treatment Choices in Older Patients with Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP160674-P2 |
| Date: | 2016 - 2018 |
| Title: | Developing a Decision Aid for Adjuvant Chemotherapy in Elderly Women with Early Stage Breast Cancer |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2016 - 2022 |
| Title: | Health Services Career Development: Improving Medical Decisions in Ovarian Cancer |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | K07 CA201013 |
| Date: | 2016 - 2018 |
| Title: | Economic Strain in Cancer Patients (Pilot Study) |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2015 - 2026 |
| Title: | Toxicities of Breast Cancer Treatment |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | PI |
| ID: | SAC150061 |
| Date: | 2015 - 2018 |
| Title: | Human Papillomavirus (HPV)-Associated Second Malignancies in Patients Who Receive Allogeneic Stem Cell Transplantation |
| Funding Source: | Duncan Family Institute |
| Role: | Collaborator |
| Date: | 2015 - 2016 |
| Title: | Trends, Utilization and Risk of Hospitalization, Toxicity and Outcomes Following Radiotherapy Compared to Other Primary Treatments for Prostate Cancer |
| Funding Source: | The Center for Radiation Oncology Research, The University of Texas MD Anderson Cancer Center |
| Role: | Mentor |
| Date: | 2014 - 2016 |
| Title: | International Male Breast Cancer Program EORTC/TBCRC/BIG/NABCG: Deeper Characterization by RNA Sequencing |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-PI |
| Date: | 2014 - 2019 |
| Title: | Methods for Training in Patient-Centered Cancer Outcomes Research |
| Funding Source: | Agency for Healthcare Research and Quality |
| Role: | Co-I |
| ID: | 1 R25 HS023214 |
| Date: | 2014 - 2026 |
| Title: | Cancer Center Support Grant: Cancer Risks and Outcomes Program |
| Funding Source: | NIH/NCI |
| Role: | Co-Leader |
| ID: | P30CA016672 |
| Date: | 2014 - 2015 |
| Title: | The Impact of Potentially Inappropriate Medication Prescribing in Elderly Cancer Patients Receiving Chemotherapy |
| Funding Source: | American Society of Clinical Oncology (ASCO) |
| Role: | Mentor |
| Date: | 2014 - 2018 |
| Title: | A Clinical and Biological Characterization of Male Breast Cancer: An International EORTC, BIG, and NABCG Intergroup Study |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | PI |
| ID: | OGEORT1301 |
| Date: | 2014 - 2016 |
| Title: | Comparative Effectiveness Research on Cancer in Texas (CERCIT) |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-Administrative Leader |
| ID: | RP140020-AC |
| Date: | 2013 - 2016 |
| Title: | Creating a Core Data Resource for Health Services Research |
| Funding Source: | Duncan Family Institute |
| Role: | PI |
| Date: | 2013 - 2017 |
| Title: | Patient Care Outcome Research in the Elderly |
| Funding Source: | Agency for Healthcare Research and Quality |
| Role: | Co-I |
| ID: | 1 R24 HS022134-01 |
| Date: | 2012 - 2018 |
| Title: | Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 1R01NR014195 |
| Date: | 2012 - 2014 |
| Title: | Using Claims Data to Evaluate Radiation Therapy Utilization at the End of Life |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5 R21 CA164449-02 |
| Date: | 2011 - 2016 |
| Title: | Innovative Methods for Modeling Longitudinal Medical Costs |
| Funding Source: | Agency for Healthcare Research and Quality |
| Role: | Consult |
| ID: | R01 HS020263 |
| Date: | 2011 - 2013 |
| Title: | Technology Diffusion & Cost-Effectiveness of Mammography Screening in Older Women |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1 R21 CA165092-01 |
| Date: | 2010 - 2014 |
| Title: | Male Breast Cancer: Understanding the Biology for an Improved Patient Care |
| Funding Source: | Breast Cancer Research Foundation |
| Role: | Co-PI |
| Date: | 2010 - 2016 |
| Title: | Assessing the Quality of Cancer Treatment in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | RP140020-P2 |
| Date: | 2010 - 2016 |
| Title: | CERCIT: Comparative Effectiveness Research on Cancer in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP101207 |
| Date: | 2010 - 2016 |
| Title: | Quality of Supportive Care of Texans with Cancer (Project 4) - Comparative Effectiveness Research on Cancer in Texas |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP140020-P4 |
| Date: | 2009 - 2013 |
| Title: | Monoclonal Antibodies in Cancer Care: Is Underinsurance an Access Barrier? |
| Funding Source: | DHHS/AHRQ |
| Role: | Co-I |
| ID: | 1-R02-HS018535-01 |
| Date: | 2009 - 2010 |
| Title: | Adherence Among Older Women with Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 3K07-CA109064-05 S1 |
| Date: | 2009 - 2014 |
| Title: | Off-Label Chemotherapy for Treatment of Cancer: Patterns, Predictors, Risks |
| Funding Source: | American Cancer Society (ACS) |
| Role: | PI |
| ID: | RSGI-09-149-01-CPHPS |
| Date: | 2009 - 2012 |
| Title: | Optimizing the Delivery of Lifestyle Interventions |
| Funding Source: | The University of Texas M. D. Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2009 - 2012 |
| Title: | Tracy Starr Breast Cancer Research Fund Award |
| Funding Source: | Cleveland Foundation |
| Role: | PI |
| ID: | L2009-0053 |
| Date: | 2009 - 2011 |
| Title: | Take Heart: Exercise & Diet Intervention for Heart Failure in Cancer Survivors |
| Funding Source: | NIH/NCI |
| Role: | Other Significant Contributor |
| ID: | CA135016-01A1 |
| Date: | 2008 - 2010 |
| Title: | Association of Breast Cancer and Its Therapies with Fracture |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R21-CA131643-01A1 |
| Date: | 2008 - 2023 |
| Title: | Training of Academic Surgical Oncologists |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| ID: | S T32 CA009599 |
| Date: | 2007 - 2010 |
| Title: | Disparities in Mammography Screening in the Rural South |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | Co-I |
| ID: | DISP0707435 03 |
| Date: | 2007 - 2011 |
| Title: | Patterns of Care and Disparities in the Treatment of Early Breast Cancer |
| Funding Source: | Department of Defense |
| Role: | Mentor |
| ID: | W81XWH-07-1-0669 03 |
| Date: | 2007 - 2007 |
| Title: | Surviving Cancer: Healthcare and Information Needs |
| Funding Source: | Texas Medical Center Fleming and Davenport Award |
| Role: | Co-I |
| Date: | 2006 - 2010 |
| Title: | Late Consequences of Therapy in Breast Cancer Survivors |
| Funding Source: | Texas Federation of Business and Professional Women's Clubs |
| Role: | PI |
| Date: | 2006 - 2007 |
| Title: | Risk of AML after Adjuvant Therapy For Breast Cancer |
| Funding Source: | Young Investigator Award, ASCO |
| Role: | Mentor |
| Date: | 2005 - 2007 |
| Title: | Burden of Breast Cancer Related Lymphedema on Working American Families |
| Funding Source: | American Cancer Society (ACS) |
| Role: | Co-I |
| ID: | RSGTL-05-093-01-CPHP |
| Date: | 2004 - 2010 |
| Title: | Adherence Among Older Women with Breast Cancer |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1K07CA109064-05 |
Patient Reviews
CV information above last modified September 08, 2026